The efficacy and safety of anti-Aβ agents for delaying cognitive decline in Alzheimer’s disease: a meta-analysis

BackgroundThis meta-analysis evaluates the efficacy and safety of amyloid-β (Aβ) targeted therapies for delaying cognitive deterioration in Alzheimer’s disease (AD).MethodsPubMed, EMBASE, the Cochrane Library, and ClinicalTrials.gov were systematically searched to identify relevant studies published...

Cijeli opis

Bibliografski detalji

Glavni autori:	Jiaxuan Li, Xin Wu, Xin Tan, Shixin Wang, Ruisi Qu, Xiaofeng Wu, Zhouqing Chen, Zhong Wang, Gang Chen
Format:	Artigo
Jezik:	Inglês
Izdano:	Frontiers Media S.A. 2023-11-01
Serija:	Frontiers in Aging Neuroscience
Teme:	Alzheimer’s disease cognitive impairment amyloid-β monoclonal antibody γ-secretase inhibitors BACE-1 inhibitors
Online pristup:	https://www.frontiersin.org/articles/10.3389/fnagi.2023.1257973/full
Oznake:	Dodaj oznaku Bez oznaka, Budi prvi tko označuje ovaj zapis!